BridgeBio Pharma, Inc. (BBIO)

67.73 -1.39 (-2.01%) USD  |  NASDAQ  |  May 26, 16:00
67.71 -0.02 (-0.03%) After-Hours: 20:00
More

BridgeBio Pharma Non-Current Portion of LTD and Capital Lease Obligation (Quarterly)

Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Cytokinetics, Inc. Upgrade